It was found that the biomarkers of efferocytosis (AXL, CD36, UCP2) and macrophage repair indicators SPMs (RvD1, RvE1, LipoxinA4) were significantly increased in animal models and postoperative colorectal cancer patients. This evidence concerns the gene UCP2 and colorectal cancer.